Discover how lenacapavir, a revolutionary HIV prevention tool, will be available for just $40 annually to 120 low- and middle ...

Low- and middle-income countries will be able to purchase an effective preventative at a reduced price. The arrangements may ...

TWN calls for generic lenacapavir to be made available to all at $40 a year: Our Bureau, New Delhi Friday, September 26, 2025, 08:00 Hrs [IST] Third World Network (TWN), an indepe ...

Cheap generic versions of a groundbreaking HIV-prevention jab should be available in more than 100 countries from 2027, ...

This antiretroviral has shown unprecedented results in HIV prevention, requiring only two injections per year. Its ...

Scientists say the drug stops the virus from replicating inside cells. The landmark deal to provide cheaper antiretroviral ...

The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir ...

Hyderabad-based drugmakers Dr. Reddy’s Laboratories and Hetero Labs have signed separate agreements that will make their generic version of Gilead Sciences’ HIV prevention drug Lenacapavir available ...

The Clinton Health Access Initiative announced its partnership with Dr. Reddy’s Laboratories, Unitaid, and Wits RHI to provide Gilead Sciences’ HIV prevention drug lenacapavir in 120 low- and ...

A new HIV prevention drug, Lenacapavir, will be made available at a significantly reduced cost in over 100 low-income countries by 2027.

Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.